← Eichor
Study identifier: NCT06973031 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Prospective Clinical Study to Evaluate the Safety and Effectiveness of Pulmonary Vein Isolation Plus Box Isolation of Fibrotic Areas With the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Condition: Paroxysmal Atrial Fibrillation (PAF) · Persistent Atrial Fibrillation  ·  Sponsor: Kardium Inc.

PhaseNA
Planned participants115
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

The study will evaluate the safety and 12-month effectiveness of the Pulmonary Vein Isolation plus Box Isolation of Fibrotic Areas (BIFA) ablation strategy with the Globe Pulsed Field System (Globe PF System) for the treatment of atrial fibrillation.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Affairs  ·  +1 (604) 248 8891  ·  Clinical.Affairs@kardium.com

Always discuss trial participation with your own doctor first.

Locations (1)

Westpfalz-Klinikum GmbH KaiserslauternKaiserslautern, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06973031